logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yiyi Yu

fudan university
H指数:26
被引数:2,144

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial

Tecotabart vedotin在Claudin 18.2阳性晚期胃/胃食管结合部癌中的研究：一项贝叶斯1/2期临床试验

European Journal of Cancer
IF7.1
2025-09-200
PRE
Chunmei Bai; Yi Zheng; Meili Sun; Jieer Ying; Fuxiang Zhou; Yiyi Yu; Ligang Xing; Yanqiao Zhang; Jinhua Wen; Heshui Wu; Xiuli Yang; Lixin Wan; Shiwei Guo; Rusen Zhao; Zhizhen Zhu; Wei Shen; Qi Wang; Shanzhi Gu; Hao Wu; Weichang Chen; Jin Xia; Jun Zhao; Xiaofang Dong; Wenhui Lou; Kuirong Jiang; Zhiye Zhang; Xiaobing Chen; Deliang Fu; Youshan Chen; Baoqing Wang; Jiaxin Liu; Yuan Ji; Shijie Yuan; Yuan Li; Zhihua Gong; Da Fei; Xia Qin; Crystal Qin; Jin Li
VIC Regimen (Vemurafenib/Irinotecan/Cetuximab) Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Unresectable or Metastatic Colorectal Cancer in Asian Patients: A Prospective Cohort Study

VIC方案 (Vemurafenib/伊立替康/西妥昔单抗) 与贝伐单抗加化疗作为一线治疗亚洲患者BRAF V600E-Mutated不可切除或转移性结直肠癌: 一项前瞻性队列研究

CLINICAL COLORECTAL CANCER
IF3.2
2024-12-010
PRE
Chen, Yijiao; Zhu, Dexiang; Yu, Yiyi; Chang, Wenju; Ye, Lechi; Feng, Qingyang; Xu, Pingping; Chen, Miao; Ji, Meiling; Wei, Ye; Liu, Tianshu; Xu, Jianmin

研究方向

暂未获取到该数据
T
Tianshu Liu
H 指数:49论文数:399被引数:1.7万
T
Tianshu Liu
H 指数:25论文数:181被引数:3,126
Y
Yuehong Cui
H 指数:26论文数:122被引数:2,310
梁
梁莉
H 指数:38论文数:316被引数:5,908
S
Shan Yu
H 指数:22论文数:79被引数:2,325
H 指数:0论文数:46被引数:358
X
Xiaojing Xu
H 指数:26论文数:103被引数:1,795
Q
Qing Liu
H 指数:37论文数:222被引数:4,055
Y
Yan Wang
H 指数:18论文数:71被引数:1,059
L
Luoyan Ai
H 指数:13论文数:38被引数:1,173